This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Nottingham. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Miguel Camara: Innovator in Biomarkers for Pseudomonas Aeruginosa Infection
Introduction
Miguel Camara is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biomedical research, particularly in the identification of biomarkers for infections caused by Pseudomonas aeruginosa. His work is crucial for improving diagnostic methods and patient outcomes.
Latest Patents
Miguel Camara holds a patent titled "Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof." This patent describes a method for determining the infection status of a subject by analyzing a sample of material obtained from them. The method involves determining the level of one or more alkyl quinolones or their metabolites produced by Pseudomonas aeruginosa or related species in the sample. He has 1 patent to his name.
Career Highlights
Camara is affiliated with the University of Nottingham, where he conducts research and collaborates with other experts in the field. His work has been instrumental in advancing the understanding of bacterial infections and their biomarkers.
Collaborations
Miguel Camara has worked alongside notable colleagues such as Paul Williams and David Barrett. Their combined expertise has contributed to the development of innovative solutions in the realm of infectious diseases.
Conclusion
Miguel Camara's contributions to the field of biomarkers for Pseudomonas aeruginosa infection highlight his role as an important inventor in biomedical research. His work continues to pave the way for advancements in diagnostic methods and patient care.